LIMITED LIABILITY COMPANY OWNERSHIP INTEREST PURCHASE AGREEMENT BY AND AMONG GENEREX BIOTECHNOLOGY CORPORATION (“GENEREX” or “BUYER”), GLOBAL MEDICAL DIRECT, LLC (“COMPANY”) AND JOSEPH CORSO, JR., ROBERT S. SHEA MARK FRANZ (“SELLERS”) October 8, 2010Limited Liability Company Ownership Interest • October 12th, 2010 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS LIMITED LIABILITY COMPANY OWNERSHIP INTEREST PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of this 8th day of October, 2010, by and among Generex Biotechnology Corporation, a Delaware corporation (“Generex” or “Buyer”), Global Medical Direct, LLC, a Kansas limited liability company (“Company”), and Joseph Corso, Jr., a New York resident (“Corso”), Robert S. Shea, a Kansas resident (“Shea”) and Mark Franz, a Kansas resident (“Franz”). Corso, Shea and Franz are each individually referred to herein as a “Seller” and collectively and jointly and severally referred to herein as the “Sellers”. Certain other capitalized terms used herein are defined in Article X and throughout this Agreement.
